Date: Tuesday 17 Apr 2012
- IMF growth forecast and Spanish debt auction lift shares
- Tech giants IBM and Intel wilt in after-hours trading
- Market applauds First Solar's decision to jettison 3 in 10 of its workers
| Exceptional items give J&J results a sickly pallor | 24-Jan-2012 | ShareCast |
| FDA recommends use of Bayer's Xarelto in the US | 09-Sep-2011 | ShareCast |
| US close: Sovereign debt talks boost shares | 21-Jul-2011 | ShareCast |
| US open: Shares enjoy EU pick-me-up | 21-Jul-2011 | ShareCast |
| US close: Bumper day for the Dow | 19-Jul-2011 | ShareCast |
| Johnson & Johnson agrees to pay £13bn for Switze... | 28-Apr-2011 | The Independent |
| S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
| J&J asks judge to dismiss kickback case | 08-Oct-2010 | Wall Street Journal |
| Genzyme Again Rejects Sanofi’s Bid | 08-Oct-2010 | New York Times |
| Johnson & Johnson buying vaccine maker Crucell | 07-Oct-2010 | USA Today |
| Currency | US Dollars |
| Share Price | $ 62.51 |
| Change Today | $ -0.59 |
| % Change | -0.94 % |
| 52 Week High | $67.92 |
| 52 Week Low | $60.20 |
| Volume | 11,208,553 |
| Shares Issued | 2,746.37m |
| Market Cap | $171,676m |
| Beta | 0.61 |
| RiskGrade | 45 |
| Strong Buy | 10 |
| Buy | 5 |
| Neutral | 13 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 28 |

| Time | Volume / Share Price |
| 16:20 | 677,202 @ $62.51 |
| 16:15 | 100 @ $62.48 |
| 16:15 | 128 @ $62.48 |
| 16:15 | 100 @ $62.48 |
| 16:15 | 100 @ $62.48 |
You are here: research